Booster shot tested to protect most vulnerable from COVID
NCT ID NCT06027229
Summary
This study tested whether a specific type of COVID-19 booster vaccine (called a recombinant vaccine) could improve and sustain immune protection in people with weakened immune systems. It focused on adults with conditions like Inflammatory Bowel Disease (IBD) or those who have received an organ transplant. Researchers measured immune responses and safety by taking blood samples before the booster, and then one month and six months after.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UW School of Medicine and Public Health
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.